Voima Ventures is a Nordic venture capital firm financing science-based companies and university spinouts across the Nordics and Baltics. Based in Helsinki and Stockholm, it invests from pre-seed through Series A and B in life sciences, medical technology, clean energy, advanced materials, quantum computing and AI. Its team combines investment experience with operating and research networks to help founders turn scientific discoveries into scalable businesses. Founded in 2019, the firm manages three funds; its Article 8 Fund III completed fundraising in 2024 and was reported at EUR 107 million in November 2025.
Founded
2020
Type
Venture capital
Funds1
Voima Ventures Fund III€107M
Nordic and Baltic early-stage deep-tech fund investing in science-based businesses in life sciences, energy, food, quantum computing and advanced AI. The manager announced a final close above EUR 100 million on December 27, 2024 and subsequently reported the same fund at EUR 107 million in November 2025. The amount field reflects that later reported total; the date records the public final-close announcement, not an inferred legal closing date. Fund III targets 25–30 companies with initial investments of EUR 200,000–3 million and follow-on capacity. It is classified as Article 8 under SFDR. Its initial EUR 90 million first close in June 2023 predates the research window.